Effectiveness of
Journal
Annals of internal medicine
ISSN: 1539-3704
Titre abrégé: Ann Intern Med
Pays: United States
ID NLM: 0372351
Informations de publication
Date de publication:
01 12 2020
01 12 2020
Historique:
pubmed:
15
9
2020
medline:
5
1
2021
entrez:
14
9
2020
Statut:
ppublish
Résumé
Current pharmacologic therapies for patients with osteoarthritis are suboptimal. To determine the efficacy of Randomized, double-blind, placebo-controlled trial. (Australian New Zealand Clinical Trials Registry: ACTRN12618000080224). Single-center study with patients from southern Tasmania, Australia. 70 participants with symptomatic knee osteoarthritis and ultrasonography-defined effusion-synovitis. 2 capsules of CL ( The 2 primary outcomes were changes in knee pain on a visual analogue scale (VAS) and effusion-synovitis volume on magnetic resonance imaging (MRI). The key secondary outcomes were change in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain and cartilage composition values. Outcomes were assessed over 12 weeks. CL improved VAS pain compared with placebo by -9.1 mm (95% CI, -17.8 to -0.4 mm [ Modest sample size and short duration. CL was more effective than placebo for knee pain but did not affect knee effusion-synovitis or cartilage composition. Multicenter trials with larger sample sizes are needed to assess the clinical significance of these findings. University of Tasmania and Natural Remedies Private Limited.
Sections du résumé
BACKGROUND
Current pharmacologic therapies for patients with osteoarthritis are suboptimal.
OBJECTIVE
To determine the efficacy of
DESIGN
Randomized, double-blind, placebo-controlled trial. (Australian New Zealand Clinical Trials Registry: ACTRN12618000080224).
SETTING
Single-center study with patients from southern Tasmania, Australia.
PARTICIPANTS
70 participants with symptomatic knee osteoarthritis and ultrasonography-defined effusion-synovitis.
INTERVENTION
2 capsules of CL (
MEASUREMENTS
The 2 primary outcomes were changes in knee pain on a visual analogue scale (VAS) and effusion-synovitis volume on magnetic resonance imaging (MRI). The key secondary outcomes were change in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain and cartilage composition values. Outcomes were assessed over 12 weeks.
RESULTS
CL improved VAS pain compared with placebo by -9.1 mm (95% CI, -17.8 to -0.4 mm [
LIMITATION
Modest sample size and short duration.
CONCLUSION
CL was more effective than placebo for knee pain but did not affect knee effusion-synovitis or cartilage composition. Multicenter trials with larger sample sizes are needed to assess the clinical significance of these findings.
PRIMARY FUNDING SOURCE
University of Tasmania and Natural Remedies Private Limited.
Substances chimiques
Plant Extracts
0
turmeric extract
856YO1Z64F
Banques de données
ANZCTR
['ACTRN12618000080224']
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM